Migraine-Specific Quality-of-Life [MSQOL-25]

Brief Description

The Migraine-Specific Quality-of-Life (MSQOL-25) is a 25-item questionnaire designed to assess the impact of migraine on different aspects of an individual’s quality of life. The instrument focuses not only on migraine symptoms themselves, but also on the way these symptoms affect everyday functioning, emotional status, and physical well-being.

The questionnaire covers three main domains:

Functional Status: the extent to which migraine affects the ability to perform everyday activities.

Emotional Status: the psychological and emotional burden associated with migraine.

Physical Health: the physical effects of migraine on health and vitality.

Aim

The primary aim of the MSQOL-25 is to assess the overall impact of migraine on the quality of life of individuals who experience it.

More specifically, the instrument helps to examine:

• the extent to which migraine affects daily life,
• the emotional and psychological burden associated with migraine,
• the physical limitations and functional impairment caused by migraine.

The MSQOL-25 may also be used to monitor changes in quality of life during therapeutic interventions or in studies evaluating the severity of migraine.

Data Analysis and Use

Responses to the MSQOL-25 are used to describe how migraine affects different aspects of patients’ lives. According to the available source material, participants usually respond using a Likert-type scale, rating the degree to which migraine affects their daily activities and overall well-being.

Data analysis may include:

Reliability analysis: to examine the internal consistency of responses, using indices such as Cronbach’s alpha.

Factor analysis: to confirm the main dimensions assessed by the questionnaire.

Correlation analysis: to investigate associations between migraine frequency or severity and quality of life.

The data may also be used in clinical studies evaluating the effectiveness of medications or other therapeutic interventions aimed at improving quality of life among individuals with migraine.

Scoring and Psychometric Evaluation

The psychometric evaluation of the MSQOL-25 includes procedures related to reliability, factor structure, and the applicability of the instrument across different populations.

Reliability analysis is used to assess the internal consistency of the scale and the stability of responses.

Factor analysis may be used to confirm the principal domains affected by migraine.

Cross-validation across different populations can help evaluate the validity and generalizability of the findings.

The available source does not provide a detailed scoring algorithm, specific cut-off values, or instructions regarding reverse-scored items. Therefore, these details cannot be established from the provided material alone.

Applications

The MSQOL-25 may be used in clinical and research settings involving individuals with migraine.

It can support:

• assessment of the impact of migraine on daily functioning,
• examination of emotional and physical burden,
• monitoring of quality of life during treatment,
• comparison of different therapeutic interventions,
• and investigation of relationships between migraine severity and quality of life.

As a migraine-specific quality-of-life measure, it provides a more targeted assessment of the burden of migraine than general quality-of-life instruments.

References

Jhingran, P., Osterhaus, J. T., Miller, D. W., Lee, J. T., & Kirchdoerfer, L. (1998). Development and validation of the migraine-specific quality of life questionnaire. Headache: The Journal of Head and Face Pain, 38(4), 295–302.

Bagley, C. L., Rendas-Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., & Lee, J. T. (2012). Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache: The Journal of Head and Face Pain, 52(3), 409–421.

Lipton, R. B., Stewart, W. F., Kolodner, K., Sawyer, J., & Liberman, J. N. (2003). Migraine impact and treatment patterns: Insights from the American Migraine Study II. Headache: The Journal of Head and Face Pain, 43(5), 624–631.